Severe hyperbilirubinemia after creation of transjugular intrahepatic portosystemic shunts: Natural history and predictors of outcome

Annals of Internal Medicine

Volumn 128, Issue 5, 1998, Pages 374-377

  Rouillard, Smita S ^a   Bass, Nathan M ^a   Roberts, John P ^a   Doherty, Catherine A ^a   Gee, Lauren ^a   Bacchetti, Peter ^a   Somberg, Kenneth A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEMOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERBILIRUBINEMIA; LIVER TRANSPLANTATION; OUTCOMES RESEARCH; PORTAL VEIN; PORTOSYSTEMIC ANASTOMOSIS; PREDICTION; PRIORITY JOURNAL;

EID: 0032030778     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-128-5-199803010-00006     Document Type: Article

References (17)

1. Ring EJ, Lake JR, Roberts JP, Gordon RL, LaBerge JM, Read AE, et al. Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med 1992;116:304-9.
2. Freedman AM, Sanyal AJ, Tisnado J, Cole P, Shiftman ML, Luketic VA, et al. Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review. Radiographics. 1993;13:1185-210.
3. LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, et al. Creation of transjugular intrahepatic shunts with the Wallstent endoprosthesis: results in 100 patients. Radiology. 1993;187:413-20.
4. Sanyal AJ, Freedman AM, Purdam PP 3d. TIPS-associated hemolysis and encephalopathy [Letter]. Ann Intern Med. 1992;117:443-4.
5. Somberg KA, Riegler JL, LaBerge JM, Doherty-Simor MM, Bacchetti P, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors. Am J Gastroenterol. 1995;90:549-55.
6. Somberg KA, Lake JR, Tomlanovich SJ, LaBerge JM, Feldstein V, Bass NM. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Hepatology. 1995;21:709-16.
7. Noeldge G, Richter GM, Roessle M, Haag K, Katzen BT, Becker GJ, et al. Morphologic and clinical results of the transjugular intrahepatic portosystemic stent-shunt (TIPSS). Cardiovasc Intervent Radiol. 1992;15:342-8.
8. Crippen JS, Schmidt RD, Niblett RL, Rees CR. Effect of a transjugular intrahepatic portosystemic shunt on liver biochemical profiles. J Vasc Interv Radiol. 1995;6:461-4.
9. Sanyal AJ, Freedman AM, Purdum PP, Shiffman ML, Luketic VA. The hematologic consequences of transjugular intrahepatic portosystemic shunts. Hepatology. 1996;23:32-9.
10. Dawson-Saunders B, Trapp RG. Basic and Clinical Biostatistics. 2d ed. Norwalk, CT: Appleton & Lange: 1994:222.
11. Gimson AE, O'Grady J, Ede RJ, Portmann B, Williams R. Late onset hepatic failure: clinical, serological and histological features. Hepatology. 1986;6:288-94.
12. Jackson FC, Perrin EB, Felix WR, Smith AG. A clinical investigation of the portocaval shunt. V. Survival analysis of the therapeutic operation. Ann Surg. 1971;174:672-701.
13. Resnick RH, Iber FL, Ishihara AM, Chalmers TC, Zimmerman H. A controlled study of the therapeutic portacaval shunt. Gastroenterology. 1974; 67:843-57.
14. Rueff B, Prandi D, Degos F, Sicot J, Degos JD, Sicot C, et al. A controlled study of therapeutic portacaval shunt in alcoholic cirrhosis. Lancet. 1976;1:655-9.
15. Conn HO. Therapeutic portacaval anastomosis: to shunt or not to shunt. Gastroenterology. 1974;67:1065-71.
16. Burchell AR, Moreno AH, Panke WF, Nealon TF Jr. Hepatic artery flow improvement after portacaval shunt: a single hemodynamic clinical correlate. Ann Surg. 1976;184:289-302.
17. Rypins EB, Sarfeh J. Influence of portal hemodynamics on long-term survival of alcoholic cirrhotic patients after small-diameter portacaval H grafts. Am J Surg. 1988;155:152-8.